Clinical trial
Nanoemulsion Curcumin for Obesity, Inflammation and Breast Cancer Prevention - a Pilot Trial
NCT01975363 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nanoemulsion Curcumin for Obesity, Inflammation and Breast Cancer Prevention - a Pilot Trial
- Lead sponsor
- Ohio State University Comprehensive Cancer Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- September 19, 2016
- Enrollment
- 29 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atypical ductal breast hyperplasia, brca1 gene mutation, brca2 gene mutation, ductal breast carcinoma in situ, lobular breast carcinoma in situ